Stockscreener 앱 받기
572.63
1.68%
8.8333
전일 마감가:
$563.80
열려 있는:
$568.01
하루 거래량:
246.35K
Relative Volume:
0.21
시가총액:
$59.66B
수익:
$14.21B
순이익/손실:
$4.46B
주가수익비율:
14.43
EPS:
39.68
순현금흐름:
$3.56B
1주 성능:
-1.09%
1개월 성능:
+0.30%
6개월 성능:
-15.13%
1년 성능:
-51.39%
1일 변동 폭
$559.62
$581.98
1주일 범위
$559.62
$588.70
52주 변동 폭
$476.49
$1,175.16
리제네론 파마슈티컬스 Stock (REGN) Company Profile
명칭
Regeneron Pharmaceuticals Inc
전화
(914) 847-7000
주소
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY
REGN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
REGN
Regeneron Pharmaceuticals Inc
|
572.70 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
VRTX
Vertex Pharmaceuticals Inc
|
398.83 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
457.06 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
737.85 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.87 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
리제네론 파마슈티컬스 Stock (REGN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-14 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-30 | 다운그레이드 | Argus | Buy → Hold |
| 2025-05-30 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-05-30 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-05-14 | 업그레이드 | Citigroup | Neutral → Buy |
| 2025-04-22 | 재개 | Cantor Fitzgerald | Overweight |
| 2025-02-05 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-01-16 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-12-10 | 재개 | BofA Securities | Underperform |
| 2024-11-15 | 개시 | Wolfe Research | Outperform |
| 2024-11-14 | 개시 | Citigroup | Neutral |
| 2024-09-24 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-03-12 | 개시 | Bernstein | Outperform |
| 2024-01-12 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | 개시 | Deutsche Bank | Hold |
| 2023-11-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2023-08-21 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2023-08-21 | 재확인 | Oppenheimer | Perform |
| 2023-06-28 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2023-03-27 | 업그레이드 | SVB Securities | Market Perform → Outperform |
| 2023-03-24 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-03-23 | 업그레이드 | Raymond James | Underperform → Mkt Perform |
| 2023-01-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2023-01-20 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2022-10-26 | 다운그레이드 | Raymond James | Mkt Perform → Underperform |
| 2022-10-17 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2022-09-09 | 업그레이드 | Jefferies | Underperform → Hold |
| 2022-09-09 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-07-25 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-07-13 | 개시 | Cantor Fitzgerald | Neutral |
| 2022-06-06 | 개시 | Jefferies | Underperform |
| 2022-05-23 | 개시 | SVB Leerink | Outperform |
| 2022-01-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-01-03 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
| 2021-12-15 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2021-12-09 | 재개 | Wells Fargo | Overweight |
| 2021-12-07 | 재개 | Cowen | Market Perform |
| 2021-12-06 | 개시 | Goldman | Buy |
| 2021-11-19 | 재개 | BMO Capital Markets | Outperform |
| 2021-11-05 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2021-06-29 | 개시 | H.C. Wainwright | Buy |
| 2021-01-25 | 업그레이드 | BMO Capital Markets | Market Perform → Outperform |
| 2021-01-13 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2021-01-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-10-05 | 업그레이드 | Cantor Fitzgerald | Neutral → Overweight |
| 2020-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2020-07-09 | 업그레이드 | SunTrust | Hold → Buy |
| 2020-05-26 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-04-28 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-04-17 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2020-04-08 | 개시 | The Benchmark Company | Hold |
| 2020-03-31 | 개시 | Wolfe Research | Peer Perform |
| 2020-02-27 | 개시 | Barclays | Overweight |
| 2020-02-26 | 업그레이드 | Canaccord Genuity | Hold → Buy |
| 2020-02-26 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-02-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2020-02-11 | 업그레이드 | Argus | Hold → Buy |
| 2019-12-24 | 개시 | Raymond James | Mkt Perform |
| 2019-12-16 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-12-13 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2019-11-12 | 개시 | SunTrust | Hold |
| 2019-11-07 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-10-17 | 재개 | BofA/Merrill | Neutral |
| 2019-09-23 | 업그레이드 | Guggenheim | Neutral → Buy |
모두보기
리제네론 파마슈티컬스 주식(REGN)의 최신 뉴스
Regeneron Pharmaceuticals’ Strategic Position in the 2025 Biotech Landscape - AInvest
Regeneron at Cantor Global Healthcare Conference: Strategic Growth and Challenges - Investing.com
Can Regeneron Pharmaceuticals Inc. reach all time highs this yearQuarterly Earnings Summary & Reliable Entry Point Trade Alerts - khodrobank.com
Prostate Cancer Pipeline Analysi, 2025 by DelveInsight | Pfizer, Janssen Pharmaceutical, POINT Biopharma, Tavanta Therapeutics, Exelixis, Astellas Pharma Inc., Antev, ORCA Therapeutics, Regeneron Phar - Barchart.com
Sporadic Inclusion Body Myositis Market: Epidemiology, - openPR.com
Regeneron Pharmaceuticals, Inc. $REGN Shares Purchased by GW Henssler & Associates Ltd. - MarketBeat
Key resistance and support levels for Regeneron Pharmaceuticals Inc.Portfolio Return Report & Free Accurate Trade Setup Notifications - Newser
Lansforsakringar Fondforvaltning AB publ Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What candlestick patterns are forming on Regeneron Pharmaceuticals Inc.Market Risk Analysis & Growth Focused Entry Reports - Newser
How to track smart money flows in Regeneron Pharmaceuticals Inc.July 2025 Sector Moves & AI Enhanced Trading Alerts - Newser
Will Regeneron Pharmaceuticals Inc. outperform the marketOptions Play & Low Volatility Stock Recommendations - Newser
How Is Regeneron’s Stock Performance Compared to Other Pharma Stocks? - MSN
How Is Regeneron’s Stock Performance Compared To Other Pharma Stocks? - Barchart.com
The Manufacturers Life Insurance Company Increases Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals Inc. stock trend forecastJuly 2025 Movers & High Conviction Trade Alerts - Newser
Real time social sentiment graph for Regeneron Pharmaceuticals Inc. - Newser
OMERS ADMINISTRATION Corp Sells 639 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Te Ahumairangi Investment Management Ltd Makes New $896,000 Investment in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Orion Investment Co Boosts Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Landscape Capital Management L.L.C. Takes $1.03 Million Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Magnetar Financial LLC Has $7.32 Million Stock Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
What are Regeneron Pharmaceuticals Inc.’s recent SEC filings showingJuly 2025 Pullbacks & Fast Gain Swing Trade Alerts - khodrobank.com
Momentum divergence signals in Regeneron Pharmaceuticals Inc. chartWeekly Earnings Recap & Low Risk High Win Rate Stock Picks - Newser
Intraday pattern recognizer results for Regeneron Pharmaceuticals Inc.July 2025 Catalysts & Safe Investment Capital Preservation Plans - Newser
Regeneron: Drug Pricing Woes Notwithstanding, Due For A Major Comeback (NASDAQ:REGN) - Seeking Alpha
Can Regeneron Pharmaceuticals Inc. expand its profit marginsWeekly Investment Recap & Accurate Entry/Exit Alerts - khodrobank.com
Wellington Management Group LLP Cuts Stake in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Kestra Advisory Services LLC Reduces Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Evercore ISI Maintains a Buy on Regeneron Pharmaceuticals (REGN) With a $750 PT - MSN
Tema Etfs LLC Has $2.73 Million Holdings in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
COPD Market Positioned for Accelerated Development Through 2034, DelveInsight Finds | Genentech, GlaxoSmithKline, Verona Pharma, Regeneron Pharma, Sanofi, MedImmune, EpiEndo Pharma, Tetherex Pharma - Barchart.com
Regeneron Pharmaceuticals, Inc. $REGN is Armistice Capital LLC's 10th Largest Position - MarketBeat
What the charts say about Regeneron Pharmaceuticals Inc. todayStock Surge & Long-Term Safe Investment Plans - Newser
What makes Regeneron Pharmaceuticals Inc. stock price move sharplyPortfolio Value Report & Free Weekly Watchlist of Top Performers - Newser
Guggenheim Capital LLC Sells 4,547 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Regeneron Pharmaceuticals (NASDAQ:REGN) Price Target Raised to $781.00 - MarketBeat
Real time alert setup for Regeneron Pharmaceuticals Inc. performanceWeekly Loss Report & Reliable Entry Point Trade Alerts - Newser
What is Regeneron Pharmaceuticals Inc. s 5 year growth outlookWeekly Investment Recap & Expert Approved Trade Ideas - khodrobank.com
Regeneron Pharmaceuticals, Inc. $REGN Holdings Increased by Comerica Bank - MarketBeat
Analyzing Regeneron Pharmaceuticals Inc. with multi timeframe charts2025 Top Decliners & Expert Approved Trade Ideas - Newser
Will Regeneron Pharmaceuticals Inc. stock recover after earnings2025 Key Highlights & Expert Verified Movement Alerts - خودرو بانک
Canada Pension Plan Investment Board Decreases Position in Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Ieq Capital LLC Acquires 4,381 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
Tools to assess Regeneron Pharmaceuticals Inc.’s risk profileLayoff News & Free Weekly Chart Analysis and Trade Guides - Newser
How to contact the Daily Bulletin - FinancialContent
Key resistance and support levels for Regeneron Pharmaceuticals IncJuly 2025 Spike Watch & Reliable Price Breakout Alerts - Newser
Harvest Portfolios Group Inc. Acquires 11,555 Shares of Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
CW Advisors LLC Purchases Shares of 1,428 Regeneron Pharmaceuticals, Inc. $REGN - MarketBeat
리제네론 파마슈티컬스 (REGN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.00%
4.09%
자본화:
|
볼륨(24시간):